Market Place
Sourcing Support
Polyphor Closes Merger with EnBiotix and is Renamed Spexis
31 Dec 2021 //
BIOSPACE
Polyphor & EnBiotix Announce Signing of Merger Agreement and Sale
01 Sep 2021 //
ACCESSWIRE
Polyphor provides update on the future of the FORTRESS study of balixafortide
19 Jul 2021 //
BLOOMBERG
Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide
28 Jun 2021 //
GLOBENEWSWIRE
Polyphor flops a phase 3, jeopardizing its future
28 Jun 2021 //
FIERCEBIOTECH
Polyphor`s breast cancer candidate shows promise in COVID-19
07 Jun 2021 //
FIERCEBIOTECH
Polyphor Announces Third Positive Data Safety Monitoring Board (DSMB)
14 Dec 2020 //
GLOBENEWSWIRE
Polyphor snags $3.3M for inhaled antibiotic
25 Nov 2020 //
FIERCE BIOTECH
Polyphor receives award of up to USD $3.3 million from Cystic Fibrosi
24 Nov 2020 //
GLOBENEWSWIRE
Polyphor completes recruitment in Phase III trial of balixafortide
30 Oct 2020 //
PHARMIWEB
Polyphor bags second grant in two years for a new class of antibiotics
14 Oct 2020 //
ENDPTS
Polyphor receives CARB-X award of up to USD 18.44M to support development
14 Oct 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.